A large-scale, real-world analysis of 15,639 patients treated with Collagenase SANTYL Ointment underscores the clinical and economic benefits of early enzymatic debridement in wound management. Using ...
Recent research is revealing key insights about the therapeutic potential of clostridial collagenase. Join us for this upcoming webinar to learn about new data on SANTYL® ointment’s unique mechanisms ...
YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the results of ...
FORT WORTH, Texas and PETERBOROUGH, Ontario, Jan. 26 Healthpoint today announced that it will begin marketing Collagenase SANTYL® Ointment to healthcare professionals in Canada. SANTYL® Ointment is a ...
FORT WORTH, Texas, April 4 /PRNewswire/-- HEALTHPOINT, Ltd., a DFB Pharmaceuticals Inc. affiliate company, today announced that it will begin marketing and selling the Collagenase SANTYL(R) Ointment ...
This episode features Dr. Jaideep Banerjee, Director of Global Clinical & Medical Affairs at Smith+Nephew, discussing the challenges of chronic wound care, the importance of standardized ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback